[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 9, 2008

The Great Debate of 2008—How Low to Go in Preventive Cardiology?

Author Affiliations

Author Affiliations: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina. Dr Peterson is also Contributing Editor, JAMA.

JAMA. 2008;299(14):1718-1720. doi:10.1001/jama.299.14.1718

The debates of 2008 have already been quite intense. During this election year, politicians and pundits alike, reviewing the same set of information, have formulated remarkably different conclusions and recommendations for national policy. The field of preventive cardiology has likewise been witness to its own debate. Spurred by a series of important yet somewhat unexpected clinical trial results, the question of “how low to go” in cardiovascular risk-factor modification has been hotly disputed.

First Page Preview View Large
First page PDF preview
First page PDF preview